Literature DB >> 3877344

Cerebral blood flow tomography with xenon-133.

N A Lassen.   

Abstract

Cerebral blood flow (CBF) can be measured tomographically by inhalation of Xenon-133. The calculation is based on taking a sequence of tomograms during the wash-in and wash-out phase of the tracer. Due to the dynamic nature of the process, a highly sensitive and fast moving single photon emission computed tomograph (SPECT) is required. Two brain-dedicated SPECT systems designed for this purpose are mentioned, and the method is described with special reference to the limitations inherent in the soft energy of the 133Xe primary photons. CBF tomography can be used for a multitude of clinical and investigative purposes. This article discusses in particular its use for the selection of patients with carotid occlusion for extracranial/intracranial bypass surgery, for detection of severe arterial spasm after aneurysm bleeding, and for detection of low flow areas during severe migraine attacks. The use of other tracers for CBF tomography using SPECT is summarized with emphasis on the 99mTc chelates that freely pass the intact blood-brain barrier. The highly sensitive brain-dedicated SPECT systems described are a prerequisite for achieving high resolution tomograms with such tracers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877344     DOI: 10.1016/s0001-2998(85)80013-1

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  10 in total

1.  Absolute cerebral blood flow measured by dynamic susceptibility contrast MRI: a direct comparison with Xe-133 SPECT.

Authors:  R Wirestam; E Ryding; A Lindgren; B Geijer; S Holtås; F Ståhlberg
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

2.  Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease.

Authors:  Y Numaguchi; J S Haller; J R Humbert; A E Robinson; W W Lindstrom; L M Gruenauer; J E Carey
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Regional cerebral blood flow by SPECT imaging in Sturge-Weber disease: an aid for diagnosis.

Authors:  C Chiron; C Raynaud; N Tzourio; C Diebler; O Dulac; M Zilbovicius; A Syrota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

4.  Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations.

Authors:  C Adamsbaum; F Pinton; Y Rolland; C Chiron; O Dulac; G Kalifa
Journal:  Pediatr Radiol       Date:  1996-11

5.  Pre- and post-operative cerebral blood flow changes in subarachnoid haemorrhage.

Authors:  J M Mountz; J E McGillicuddy; M W Wilson; S P Bartold; E M Siegal
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

6.  Early single photon emission computed tomography in Sturge-Weber syndrome.

Authors:  F Pinton; C Chiron; O Enjolras; J Motte; A Syrota; O Dulac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

7.  Cerebral blood flow thresholds for tissue infarction in patients with acute ischemic stroke treated with intra-arterial revascularization therapy depend on timing of reperfusion.

Authors:  K Mui; A J Yoo; L Verduzco; W A Copen; J A Hirsch; R G González; P W Schaefer
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-07       Impact factor: 3.825

8.  Evaluation of cerebral vasospasm in patients with subarachnoid hemorrhage using single photon emission computed tomography.

Authors:  S Naderi; M A Ozgüven; H Bayhan; H Gökalp; A Erdoğan; N Egemen
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

9.  The investigation of dementia syndromes by 133Xenon dynamic single photon emission computed tomography.

Authors:  F M Reischies; J P Hedde; H Gutzmann
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

10.  Initial experience with SPECT of the brain using 99mTc-hexamethyl-propyleneamine oxime (99mTc-HM-PAO).

Authors:  G Spreafico; F Cammelli; G Gadola; G Nicola; F Zancaner; G Tonnarelli; E Sala; R Freschi
Journal:  Eur J Nucl Med       Date:  1987
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.